Adaptimmune Therapeutics plc (ADAP): Price and Financial Metrics
ADAP Price/Volume Stats
| Current price | $0.66 | 52-week high | $2.05 |
| Prev. close | $0.67 | 52-week low | $0.42 |
| Day low | $0.64 | Volume | 4,159,800 |
| Day high | $0.71 | Avg. volume | 1,733,159 |
| 50-day MA | $0.85 | Dividend yield | N/A |
| 200-day MA | $1.12 | Market Cap | 170.09M |
ADAP Stock Price Chart Interactive Chart >
Adaptimmune Therapeutics plc (ADAP) Company Bio
Adaptimmune Therapeutics plc is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. The company was founded in 2014 and is based in Abingdon, the United Kingdom.
ADAP Price Returns
| 1-mo | -18.52% |
| 3-mo | -45.45% |
| 6-mo | -37.14% |
| 1-year | 46.99% |
| 3-year | -83.90% |
| 5-year | -21.01% |
| YTD | -16.77% |
| 2023 | -45.68% |
| 2022 | -61.07% |
| 2021 | -30.43% |
| 2020 | 349.17% |
| 2019 | -79.13% |
Continue Researching ADAP
Here are a few links from around the web to help you further your research on Adaptimmune Therapeutics PLC's stock as an investment opportunity:Adaptimmune Therapeutics PLC (ADAP) Stock Price | Nasdaq
Adaptimmune Therapeutics PLC (ADAP) Stock Quote, History and News - Yahoo Finance
Adaptimmune Therapeutics PLC (ADAP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...